Learn how Dupixent may be linked to CTCL

Did you or a loved one develop lymphoma after starting Dupixent injections? You may be eligible to take legal action and seek compensation. Complete the confidential form on this page to learn more about the Dupixent lawsuit.
Dupixent is a prescription medication commonly used to treat eczema, asthma and other inflammatory conditions. While it has helped many patients manage their symptoms, recent clinical reports have linked Dupixent injections to rare but serious cancers, including Cutaneous T-Cell Lymphoma (CTCL) and related T-cell lymphomas.
If you or a loved one received Dupixent and were later diagnosed with CTCL or another lymphoma, it is important to understand your legal options, including whether you may qualify for a Dupixent lawsuit.
Do you qualify?
If you received Dupixent injections for 3 to 6 months and were later diagnosed with CTCL or any of the following cancers, you may be eligible to file a Dupixent lawsuit:
- Cutaneous T-Cell Lymphoma (CTCL)
- Mycosis Fungoides
- Sézary Syndrome
- Lymphomatoid Papulosis
- Anaplastic Large Cell Lymphoma
- Extranodal Natural Killer (NK) T-Cell Lymphoma
- Subcutaneous Panniculitis-Like T-Cell Lymphoma
- Adult T-Cell Leukemia/Lymphoma
- Follicular Helper T-Cell Lymphoma
- Peripheral T-Cell Lymphoma
To determine if you qualify, please complete the confidential form on this page.
Fill out the form on this page for more information.
What is Dupixent and how is it linked to Cutaneous T-Cell Lymphoma?
Dupixent is a prescription injectable medication commonly used to treat eczema (atopic dermatitis), asthma, chronic obstructive pulmonary disease (COPD), and other inflammatory conditions. It works by targeting specific proteins in the immune system to reduce inflammation and is approved for use in adults and children as young as six.
While Dupixent can be effective for these conditions, recent clinical reports have identified cases in which patients developed Cutaneous T-Cell Lymphoma (CTCL) after starting the medication. In many instances, these diagnoses occurred within a year of the first Dupixent injection.
Types of cancer potentially linked to Dupixent
Research and clinical reports have suggested a potential link between Dupixent and several types of rare blood and skin cancers. Individuals who have received Dupixent and were later diagnosed with any of the following conditions may qualify to take part in a Dupixent lawsuit:
- Cutaneous T-Cell Lymphoma (CTCL)
- Mycosis Fungoides
- Sézary Syndrome
- Lymphomatoid Papulosis
- Anaplastic Large Cell Lymphoma
- Extranodal Natural Killer (NK) T-Cell Lymphoma
- Subcutaneous Panniculitis-Like T-Cell Lymphoma
- Adult T-Cell Leukemia/Lymphoma
- Follicular Helper T-Cell Lymphoma
- Peripheral T-Cell Lymphoma
How to file a Dupixent lawsuit
If you or a loved one received a CTCL diagnosis that may be linked to Dupixent injections, you could be eligible to take legal action.
To begin the process, please complete the confidential form on this page to share your experience. A legal professional will review your case and may contact you to discuss your options.
Fill out the form on this page to see if you qualify for a free case evaluation.
The law firms responsible for the content of this page are: Accident Injury Lawyers, PA / 866-481-5347 / dolmanlaw.com, and LegaFi Law LLC (an Arizona law firm) / 888-4-LegaFi / www.legafi.com
See If You Qualify
Join a Dupixent lawsuit investigation
Filling out this form is quick and easy. It only takes a few minutes to see if you qualify.
After you fill out the form, an attorney(s) or their agent(s) may contact you to discuss your legal rights.
ATTORNEY ADVERTISING
The choice of a lawyer is an important decision and should not be based solely on advertisements.
PAID ATTORNEY ADVERTISEMENT: THIS WEB PAGE IS AN ADVERTISEMENT AND THE PARTICIPATING ATTORNEY(S) ARE INCLUDED BECAUSE THEY PAY AN ADVERTISING FEE. Top Class Actions is not a law firm, lawyer referral service, or prepaid legal services plan. We do not endorse or recommend any third-party claims processing company, lawyer, or law firm who participates in the network. We do not make any representation, and have not made any judgment, as to the qualifications, expertise, or credentials of any participating lawyer or processing group. No representation is made that the quality of the legal services or claims processing to be performed is greater than the quality of legal services or claims processing performed by other lawyers or claims processing group. The information contained herein is not legal advice. Any information you submit to Top Class Actions does not create an attorney-client relationship and may not be protected by attorney-client privilege because Top Class Actions is not a law firm. Instead, your information will be forwarded to an attorney(s) or their agent(s) or a claims processing firm for the purpose of a confidential review and potential representation if you qualify. You will only be contacted by an attorney(s) or their agent(s) in response to your inquiry if your initial information appears to qualify you for representation. If you are not contacted by an attorney(s) or their agent(s) within one week, you should consult another firm since all legal claims are subject to filing deadlines. All photos on this website are stock art and do not depict clients.